Skip to content

Study · Not a test of the peptide alone · 2008

2 results

[The effect of heavy metal ions and peptide bioregulators on the expression of chromosome fragile sites in the individuals of different age groups and breast cancer patients].

Dzhokhadze TA, Ganozishvili MN, Lezhava TA

Georgian medical news1 Sept 2008

PMID18830022 (opens in a new tab)PepBankPUB-18830022

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Epitalon.

  1. 01LabNot a test of Epitalon aloneIn vitro (cells)Efficacy outcome

    In lymphocyte cultures from healthy young individuals, the bioregulators Livagen and epithalon lessened the effect of heavy metals on chromosome fragile sites.

    In plain wordsIn lab cells from healthy young donors, epithalon and Livagen reduced the effect of heavy metals on chromosome fragile sites.

    Peptide
    Epitalon
    Outcome
    DecreaseHeavy metal effect on fragile sites, young group
    Study

    humann: not reported in source

    Short-term lymphocyte cultures
    Outcome group
    Genome stability · Aging and longevity

    Source sentences

    Summary
    Both tested bioregulators lessen heavy metals effect that was statistically reliable only for the young people group.
    2 context sentences
    Summary · context
    In individuals with a normal check-up of different age groups the heavy metal (nickel, zinc and cobalt) ions were also examined on their influence on the expression of the fragile sites and the peptide bioregulators (Livagen and Epithalon) were tested on their ability to correct the pattern of expression.
    Summary · context
    Short-term lymphocyte cultures were used as tested material.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

  2. 02LabNot a test of Epitalon aloneIn vitro (cells)Efficacy outcome

    In lymphocyte cultures from healthy older individuals, the reduction of the heavy metal effect on fragile sites by Livagen and epithalon was not statistically reliable.

    In plain wordsIn lab cells from healthy older donors, the reduction by epithalon and Livagen was not statistically reliable.

    Peptide
    Epitalon
    Outcome
    No significant changeHeavy metal effect on fragile sites, old group
    Study

    humann: not reported in source

    Short-term lymphocyte cultures
    Outcome group
    Genome stability · Aging and longevity

    Source sentences

    Summary
    Both tested bioregulators lessen heavy metals effect that was statistically reliable only for the young people group.
    2 context sentences
    Summary · context
    In individuals with a normal check-up of different age groups the heavy metal (nickel, zinc and cobalt) ions were also examined on their influence on the expression of the fragile sites and the peptide bioregulators (Livagen and Epithalon) were tested on their ability to correct the pattern of expression.
    Summary · context
    Short-term lymphocyte cultures were used as tested material.

    In this study, Epitalon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Epitalon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Versions 4 to 10Current

    28 Oct 2026, 02:02 UTC

    The same notice was added 7 times, first on 21 Oct 2026, 17:05 UTC. The status did not change between them.

    Study results updated

  2. Version 3

    21 Oct 2026, 16:35 UTC

    Study data updated · source update from Europe PMC

  3. Version 2

    12 Oct 2026, 17:28 UTC

    Study results updated

  4. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.